Identifying Interventions To Delay Or Prevent Breast Cancer Recurrences After Tamoxifen
12/08/2011
An international research team led by Georgetown Lombardi Comprehensive Cancer Center has found biological differences in hormone-receptor positive breast cancer that are linked to the timing of recurrence despite endocrine therapy...
Clodronate Appeared Safe, Modestly Affected Breast Cancer Disease Events
12/08/2011
A recently presented study revealed that the bisphosphonate clodronate had a low incidence of adverse events and toxicity among patients with breast cancer and may modestly reduce the incidence of distant metastases in postmenopausal women...
After Partial Breast Irradiation, Side Effects, Complications, Mastectomy More Likely
12/08/2011
Accelerated partial breast irradiation (APBI) brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate of later mastectomy, increased radiation-related toxicities and post-operative complications, compared to traditional whole breast irradiation (WBI), accor...
Computer Aided Design Advances Breast Reconstruction
12/08/2011
Breast reconstruction surgery will become both safer and more realistic thanks to research led by Queensland University of Technology (QUT). Professor Dietmar W...
Researchers may have discovered a series of genes that will help predict whether or not a woman with hormone receptor-positive invasive breast cancer will experience early, late or no recurrence of her disease. Minetta C. Liu, M.D...
Predicting Risk For Recurrence For Patients With DCIS Breast Cancer
12/08/2011
In a significant advance for patients with ductal carcinoma in situ, researchers have developed and prospectively validated a multigene test to identify the risk for recurrence of breast cancer...
Anemia In Dialysis Patients - Peginesatide Gets Green Light From FDA Advisory Panel
12/08/2011
An FDA Advisory Committee has voted in favour of approving peginesatide for use with dialysis patients who developed anemia caused by CKD (chronic kidney disease). The Oncologic Drugs Advisory Committee (ODAC) voted 15 in favor, 1 against, with 1 abstention. Peginesatide is an ESA (synthetic erythropoiesis-stimulating agent)...
Predicting Who Might Benefit From Additional Gastrointestinal Cancer Treatment - New Predictive Tool
12/07/2011
According to a study published Online First in The Lancet Oncology, a new tool that can assess a person's risk of gastrointestinal stromal tumors recurrence after surgery is an important addition to current predictive models that will also help with the development of more accurate selection of high-risk patients who are most likely to benefit from additional treatment...
Triple Drug Combo Eradicates 50% More Tumors In HER2-Positive Breast Cancer Than Standard Treatment
12/07/2011
Findings of the phase 2 NeoSphere study, published Online First in The Lancet Oncology shows that by adding monoclonal antibody pertuzumab to standard therapy (trastuzumab [Herceptin] plus the chemotherapy drug docetaxel) for women with an aggressive type of early-stage breast cancer (HER2-positive disease) improved the rate of complete tumor disappearance by over half after just four cycles, i.e...
Chemotherapy Lowers Breast Cancer Mortality By One Third - 100 Trials Demonstrate
12/07/2011
Oxford University researchers have demonstrated that modern chemotherapy reduces breast cancer mortality by approximately one third in a large number of patients, compared with no chemotherapy...